Answer
Yes, for licensed invasive fungal infections, but age eligibility differs between oral and intravenous formulations. Specialist paediatric oversight is required.
Sources for this answer
- CRESEMBA 200mg Powder for concentrate for solution for infusionemc · SmPC Current selected SmPC · Version 22
- Cresemba 100mg Hard Capsulesemc · SmPC Current selected SmPC · Version 11